denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Sponsor: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Genentech, a member of the Roche Group, Incyte Corporation, Karyopharm Therapeutics Inc and Seattle Genetics
Program: Satellite Symposia
Hematology Disease Topics & Pathways:
Follicular Lymphoma, Diseases, Lymphoma (any), Hodgkin Lymphoma, Mantle Cell Lymphoma, Non-Hodgkin Lymphoma, DLBCL, Lymphoid Malignancies
Hematology Disease Topics & Pathways:
Follicular Lymphoma, Diseases, Lymphoma (any), Hodgkin Lymphoma, Mantle Cell Lymphoma, Non-Hodgkin Lymphoma, DLBCL, Lymphoid Malignancies
Friday, December 4, 2020: 7:00 PM-10:00 PM
Chair:
Neil Love, MD, Research To Practice
Disclosures:
No relevant conflicts of interest to declare.
Speakers:
Jonathan W. Friedberg, MD, MSSc, James P. Wilmot Cancer Center, University of Rochester
,
John Kuruvilla, MD, Princess Margaret Cancer Centre, The Princess Margaret Hospital
,
Ann S. LaCasce, MD, MSc, Dana-Farber Cancer Institute, Dana-Farber Cancer Inst.
,
John P. Leonard, MD, Weill Cornell Medical College, Weill Med. College of Cornell University
and
Michael E. Williams, MD, University of Virginia Health System, University of Virginia
Disclosures:
Friedberg: Roche: Other: Travel expenses; Portola Pharmaceuticals: Consultancy; Astellas: Consultancy; Seattle Genetics: Research Funding; Acerta Pharma — A member of the AstraZeneca Group, Bayer HealthCare Pharmaceuticals.: Other; Bayer: Consultancy; Kite Pharmaceuticals: Research Funding. Kuruvilla: Seattle Genetics: Consultancy, Honoraria; Karyopharm: Consultancy, Honoraria; AstraZeneca Pharmaceuticals LP: Honoraria, Research Funding; Gilead: Consultancy, Honoraria; Novartis: Honoraria; TG Therapeutics: Honoraria; AbbVie: Consultancy; Antengene: Honoraria; Merck: Consultancy, Honoraria; Bristol-Myers Squibb Company: Consultancy; Pfizer: Honoraria; Roche: Consultancy, Honoraria, Research Funding; Celgene Corporation: Honoraria; Janssen: Honoraria, Research Funding; Amgen: Honoraria. LaCasce: Research to Practice: Speakers Bureau; BMS: Consultancy; UptoDate: Patents & Royalties. Leonard: Karyopharm: Consultancy; Roche/Genentech: Consultancy; AstraZeneca: Consultancy; ADC Therapeutics: Consultancy; Regeneron: Consultancy; Sutro: Consultancy; MEI Pharma: Consultancy; Epizyme: Consultancy; GenMab: Consultancy; BMS/Celgene: Consultancy; Bayer: Consultancy; Miltenyi: Consultancy; Gilead/Kite: Consultancy. Williams: Celgene Corporation, Gilead Sciences Inc, TG Therapeutics Inc: Consultancy; AbbVie Inc;: Other; Xian Janssen Pharmaceutical Ltd.: Speakers Bureau; Allos Therapeutics, Celgene Corporation, Gilead Sciences Inc, Janssen Biotech Inc, Pharmacyclics LLC, an AbbVie Company, TG Therapeutics Inc: Research Funding.
This activity, the fourth of a 4-part live webinar series, will feature 5 lymphoma investigators serving as faculty. Research To Practice (RTP) president Dr Neil Love will moderate the program. Prior to live webinar, the faculty plus 3 other investigators will complete a pre-survey to ascertain their perspectives on controversial questions/scenarios related to the management of Hodgkin and NHL, including FL, mantle cell and DLBCL. Responses from all 8 investigators will be depicted as Treatment Preference Matrices (TPMs). Additionally, RTP will conduct a Patterns of Care (POC) survey of 75 US general oncologists featuring many of the same questions posed to the experts. Findings from the surveys will serve as the foundation for the FSS virtual program on Dec 4th. The live webcast will be divided into 5 modules, with each featuring 2 segments — (1) discussion of a series of TPMs and (2) corresponding POC survey results and a faculty member-led review of emerging clinical research. Throughout the session, Dr Love will ask participating faculty to discuss the rationale for their TPM responses & shed light on any discrepancies and/or practice gaps. To make the program more interactive, attendees will be able to use RTP’s enhanced webinar interface to pose questions to Dr Neil Love and the faculty as well as to complete a pre-meeting survey, from which the results will be juxtaposed with the TPMs & POC survey results to foster additional debate during the webinar.
For more information, please email us at Meetings@ResearchToPractice.com or call us at 1 (800) 233-6153 (toll free, US only) or +1 (305) 377-2828 (international). To learn more about this webinar series please visit our website: http://www.researchtopractice.com/Meetings/FSS2020.
See more of: Satellite Symposia